ABPI statement on the death of Aisling Burnand

The former CEO of the Association of Medical Research Charities, Aisling Burnand, has died from bowel cancer. 

Aisling was a powerhouse in advocating for the change needed to improve the lives of patients. She provided inspirational leadership and a powerful voice for the role that medical research charities play in the life sciences sector and will be very much missed by many. Richard Torbett, Chief Executive, ABPI

In response to this sad news, ABPI Chief Executive Richard Torbett said: 

“Everyone at the ABPI is deeply saddened to hear of the death of Aisling Burnand.

 

“Aisling was a powerhouse in advocating for the change needed to improve the lives of patients.  Colleagues across the ABPI worked closely with Aisling throughout her career, including in her roles leading the BioIndustry Association and the Association of Medical Research Charities.  She provided inspirational leadership and a powerful voice for the role that medical research charities play in the life sciences sector and will be very much missed by many.

 

“On behalf of all at the ABPI, I would like to extend our condolences to Aisling’s family, friends and all those that knew her.”

 

If you would like to make a donation, please support the work of Bowel Cancer UK (https://www.bowelcanceruk.org.uk/support-us/ways-to-donate/

Last modified: 20 September 2023

Last reviewed: 20 September 2023

The ABPI exists to make the UK the best place in the world to research, develop and use new medicines. We represent companies of all sizes who invest in discovering the medicines of the future. 

Our members supply cutting edge treatments that improve and save the lives of millions of people. We work in partnership with Government and the NHS so patients can get new treatments faster and the NHS can plan how much it spends on medicines. Every day, we partner with organisations in the life sciences community and beyond to transform lives across the UK.